Study on the Safety and Tolerability of Postoperative Radiotherapy Concurrent With CDK4/6 Inhibitors in HR+/HER2- High-Risk Breast Cancer
Clinical trial NCT07446686 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07446686
- Sponsor
- Guizhou Provincial People's Hospital
- Status
- NOT_YET_RECRUITING
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-04-01
- Primary completion
- 2027-04-30
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.